Literature DB >> 20602100

Systemic inflammatory response in gastric cancer.

Hiroharu Yamashita1, Hitoshi Katai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20602100     DOI： 10.1007/s00268-010-0703-1

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  10 in total

1.  Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.

Authors:  Campbell S D Roxburgh; Jonathan M Salmond; Paul G Horgan; Karin A Oien; Donald C McMillan
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

2.  Prognostic significance of host- and tumor-related factors in patients with gastric cancer.

Authors:  Yasuhiko Mohri; Kouji Tanaka; Masaki Ohi; Takeshi Yokoe; Chikao Miki; Masato Kusunoki
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

3.  Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?

Authors:  Andrew B C Crumley; Robert C Stuart; Margaret McKernan; Donald C McMillan
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 4.  An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.

Authors:  Donald C McMillan
Journal:  Proc Nutr Soc       Date:  2008-05-01       Impact factor: 6.297

Review 5.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

6.  Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Keiichi Kubota
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

7.  Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.

Authors:  D A C Deans; S J Wigmore; H Gilmour; S Paterson-Brown; J A Ross; K C H Fearon
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

8.  An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.

Authors:  A B C Crumley; D C McMillan; M McKernan; J J Going; C J Shearer; R C Stuart
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

9.  Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.

Authors:  Do-Kyong Kim; Sung Yong Oh; Hyuk-Chan Kwon; Suee Lee; Kyung A Kwon; Byung Geun Kim; Seong-Geun Kim; Sung-Hyun Kim; Jin Seok Jang; Min Chan Kim; Kyeong Hee Kim; Jin-Yeong Han; Hyo-Jin Kim
Journal:  BMC Cancer       Date:  2009-05-20       Impact factor: 4.430

10.  Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; W J Angerson; D J Dunlop
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640
  10 in total
  10 in total

1.  The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.

Authors:  Yoshiaki Ikuta; Hiroshi Takamori; Yasuo Sakamoto; Daisuke Hashimoto; Akira Chikamoto; Hideyuki Kuroki; Kazuya Sakata; Keita Sakamoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Masahiko Hirota; Keiichiro Kanemitsu; Toru Beppu; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2013-09-03       Impact factor: 3.402

2.  Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer.

Authors:  Yusuke Nakayama; Naoto Gotohda; Hidehito Shibasaki; Shogo Nomura; Takahiro Kinoshita; Ryuichi Hayashi
Journal:  Surg Today       Date:  2014-05-16       Impact factor: 2.549

3.  Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel.

Authors:  Ahmet Taner Sümbül; Ahmet Sezer; Hüseyin Abalı; Fatih Köse; Ilhami Gültepe; Hüseyin Mertsoylu; Sadık Muallaoğlu; Özgür Özyılkan
Journal:  Int Urol Nephrol       Date:  2014-02-13       Impact factor: 2.370

4.  Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.

Authors:  Jun-Eul Hwang; Ha-Na Kim; Dae-Eun Kim; Hyun-Jung Choi; Sung-Hoon Jung; Hyun-Jeong Shim; Woo-Kyun Bae; Eu-Chang Hwang; Sang-Hee Cho; Ik-Joo Chung
Journal:  BMC Cancer       Date:  2011-11-21       Impact factor: 4.430

5.  Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer.

Authors:  Jing Chen; Dongsheng Hong; You Zhai; Peng Shen
Journal:  World J Surg Oncol       Date:  2015-03-26       Impact factor: 2.754

6.  Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Mariusz Koda; Małgorzata Grudzińska; Luiza Kańczuga-Koda; Waldemar Famulski
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

7.  Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents.

Authors:  Seong Hyeon Yu; Je Guk Ryu; Se Heon Jeong; Eu Chang Hwang; Won Seok Jang; In Sang Hwang; Ho Song Yu; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Jun Eul Hwang; Geun Soo Kim
Journal:  Korean J Urol       Date:  2013-05-14

8.  Clinical significance of preoperative inflammatory parameters in gastric cancer patients.

Authors:  Deuk Young Lee; Seong Woo Hong; Yeo Goo Chang; Woo Yong Lee; Byungmo Lee
Journal:  J Gastric Cancer       Date:  2013-06-25       Impact factor: 3.720

9.  Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance?

Authors:  Zhihao Lu; Li Yang; Jingwei Yu; Ming Lu; Xiaotian Zhang; Jian Li; Jun Zhou; Xicheng Wang; Jifang Gong; Jing Gao; Jie Li; Yan Li; Lin Shen
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.

Authors:  Xiaowei Sun; Xuechao Liu; Jianjun Liu; Shangxiang Chen; Dazhi Xu; Wei Li; Youqing Zhan; Yuanfang Li; Yingbo Chen; Zhiwei Zhou
Journal:  Chin J Cancer       Date:  2016-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.